Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: A systematic review

Laryngoscope

Volumn 116, Issue 1, 2006, Pages 144-148

  Karkos, Petros D ^a   Wilson, Janet A ^a,b  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Gastroesophageal; Laryngopharyngeal; Larynx; Proton pump inhibitors; Reflux; Treatment

Indexed keywords

ANTACID AGENT; ESOMEPRAZOLE; FAMOTIDINE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; PROTON PUMP;

CLINICAL TRIAL; DISEASE SEVERITY; EMPIRICISM; HUMAN; LARYNGOPHARYNGEAL REFLUX; LARYNGOSCOPY; METHODOLOGY; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HOSPITALIZATION; HYPOPHARYNX; MALE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; STOMACH PH;

ADMINISTRATION, ORAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HUMANS; HYPOPHARYNX; MALE; OMEPRAZOLE; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33645234361     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000191463.67692.36     Document Type: Review

References (32)

1. Koufman JA, Aviv JE, Casiano RR, et al. Laryngopharyngeal reflux: Position Statement of the Committee on Speech, Voice, and Swallowing Disorders of the American Academy of Otolaryngology-Head Neck Surgery. Otolaryngol Head Neck Surg 2002;127: 32-35.
2. Tasker A, Dettmar PW, Panetti M, et al. Is gastric reflux a cause of otitis media with effusion in children? Laryngoscope 2002;112:1930-1934.
3. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101(suppl 53):1-78.
4. Ylitalo R, Lindestad P, Ramel S. Symptoms, laryngeal findings, and 24-hour pH monitoring in patients with suspected gastroesophago-pharyngeal reflux. Laryngoscope 2001;111:1735-1741.
5. Weiner GJ, Koufman JA, Wu WC, et al. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-hour pH monitoring. Am J Gastroenterol 1989;84:1053-1058.
6. Jamieson JR, Stein HJ, DeMeester TR, et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992;87:1102-1111.
7. Kamel PL, Hanson D, Kahrilas PJ. Omeprazole for the treatment of posterior laryngitis. Am J Med 1994;96:321-326.
8. Hanson DG, Kamel PL, Kahrilas PJ. Outcomes of antireflux therapy for the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol 1995;104:550-555.
9. Jaspersen D, Weber R, Hammar CH, et al Effect of omeprazole on the course of associated esophagitis and laryngitis. J Gastroenterol 1996;31:765-767.
10. Shaw GY, Searl JP, Young JL, et al. Subjective, laryngoscopic, and acoustic measurements of laryngeal reflux before and after treatment with omeprazole. J Voice 1996;10:410-418.
11. Metz DC, Childs ML, Ruiz C, Weinstein GS. Pilot study of the oral omeprazole test for reflux laryngitis. Otolaryngol Head Neck Surg 1997;116:41-46.
12. Shaw GY, Searl JP. Laryngeal manifestations of gastroesophageal reflux before and after treatment with omeprazole. South Med J 1997;90:1115-1122.
13. Wo JM, Grist WJ, Gussack G, et al. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. Am J Gastroenterol 1997;92:2160-2165.
14. Habermann W, Eherer A, Lindbichler F, et al. Ex juvantibus approach for chronic posterior laryngitis results of short-term pantoprazole therapy. J Laryngol Otol 1999;113:734-739.
15. Fossati D, Passaretti S, Strada E, et al ENT disorders caused by GERD: efficacy of treatment with pantoprazole. Gastroenterology 2000;118(suppl 2):5650-5651.
16. Habermann W, Kiesler K, Eherer A, et al. Short-term therapeutic trial of proton pump inhibitors in suspected extraesophageal reflux. J Voice 2002;16:425-432.
17. Rodriguez-Tellez M, Galera-Ruiz H, Arguelles-Arias F, et al. Posterior laryngitis: effects of treatment with omeprazole alone. Rev Esp Enferm Dig 2002;94:123-130.
18. Garrigues V, Gisbert L, Bastida G, et al. Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based clinical practice. Dig Dis Sci 2003;48:2117-2123.
19. DelGaudio JM, Waring JP. Empiric esomeprazole in the treatment of laryngopharyngeal reflux. Laryngoscope 2003;113:598-601.
20. Siupsinskiene N, Adamonis K. Diagnostic test with omeprazole in patients with posterior laryngitis. Medicina 2003;39:47-55.
21. Bilgen C, Ogut F, Kesimli-Dinc H, et al. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe pH monitoring in laryngopharyngeal reflux. J Laryngol Otol 2003;117:386-390.
22. Havas T, Huang S, Levy M, et al. Posterior pharyngolaryngitis: double-blind randomised placebo-controlled trial of proton pump inhibitor therapy. Aust J Otolaryngol 1999;3:243-246.
23. El-Serag HB, Lee P, Buchner A, et al. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001;96:979-983.
24. Noordzij JP, Khidr A, Desper E, et al. Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope 2002;112:2192-2195.
25. Eherer AJ, Habermann HF, Klesler K, et al. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol 2003;38:462-467.
26. Steward DL, Wilson KM, Kelly DH, et al. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 2004;131:342-350.
27. Vaezi M, Richter J, Stasney SR, et al. A randomized, double blind, placebo-controlled study of acid suppression for the treatment of suspected laryngopharyngeal reflux [Abstract]. Gastroenterology 2004;126(suppl 2):A22.
28. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the Reflux Finding Score (RFS). Laryngoscope 2001;111:1313-1317.
29. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the Reflux Symptom Index (RSI). J Voice 2002;16:274-277.
30. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 2003;33:1023-1029.
31. Book DT, Rhee JS, Toohill RJ, et al. Perspectives in laryngopharyngeal reflux: an international survey. Laryngoscope 2002;112:1399-1406.
32. Altman KW, Haines GK 3rd, Hammer ND, et al. The H+/K+-ATPase (proton) pump is expressed in human laryngeal submucosal glands. Laryngoscope 2003;113:1927.